Cervical cancer screening in patients at a tertiary care centre with Pap smear and HPV DNA testing
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253080Keywords:
Transformation zone, Cold knife conization, Loop electrosurgical excision procedure, High risk, Human papilloma virusAbstract
Background: Cervical cancer ranks fourth among the most commonly diagnosed cancers as well as the fourth leading cause of cancer mortality in women globally. Of all new cases and deaths worldwide in 2020, India accounted nearly one-fourth of deaths due to cervical cancer. In India, cervical cancer is the second most common cancer in both incidence 18.3% and cancer mortality 18.7% among women in 2020, with a 5-year prevalence of 18.8%.
Methods: A hospital based cross sectional study was conducted in the Gynecology OPD of PBM Hospital, Bikaner. 118 women aged 19-60 years presenting with complaints such as unusual bleeding between periods/after menopause/after sexual intercourse; increased or foul-smelling vaginal discharge etc were included. A questionnaire was administered containing general information, clinical findings at pelvic evaluation. They then underwent Pap smear, HPV testing and histo-pathology. Appropriate statistical tests were used to compare the outcome between the sub-groups.
Results: Pap smear offered high specificity (~93.9%) and a strong NPV (99.1%), with a low positive predictive value (PPV~18%-25%) indicating a high false-positive rate, necessitating triage with confirmatory tests. HPV DNA testing emerged as the superior tool, with 100% sensitivity and NPV. Its specificity was over 95% and PPV was 37.5%.
Conclusions: HPV DNA testing is the most accurate screening test, reflecting its utility in early detection of high-risk cases.
Metrics
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. DOI: https://doi.org/10.3322/caac.21660
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimina tion Initiative. Lancet Glob Health. 2023;11(2):197–206. DOI: https://doi.org/10.1016/S2214-109X(22)00501-0
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27. DOI: https://doi.org/10.1056/NEJMoa021641
Papillomaviruses H. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France. IARC. 2011.
Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244-65. DOI: https://doi.org/10.1136/jcp.55.4.244
Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer. 2004;112(2):341-7. DOI: https://doi.org/10.1002/ijc.20396
Sankaranarayanan R, Boffetta P. Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol. 2010;21(10):1935-43. DOI: https://doi.org/10.1093/annonc/mdq049
Gravitt PE, Paul P, Katki HA, Vendantham H, Ramakrishna G, Sudula M, et al. CATCH Study Team. Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India. PLoS One. 2010;5(10)13711. DOI: https://doi.org/10.1371/journal.pone.0013711
Subramanian L, Indirani TV, Suji I IS. Comparing effectiveness of COBAS HPV test with VIA/VILI, pap smear and colposcopy for screening of cancer cervix. Indian J Obst Gynecol Res. 2021;8(4):525–30. DOI: https://doi.org/10.18231/j.ijogr.2021.108
Ramamoorthy T, Sathishkumar K, Das P, Sudarshan KL, Mathur P. Epidemiology of human papillomavirus related cancers in India: findings from the National Cancer Registry Programme. Ecancermedicalscience. 2022;16:1444. DOI: https://doi.org/10.3332/ecancer.2022.1444
Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385–94. DOI: https://doi.org/10.1056/NEJMoa0808516
Joshi S, Sankaran S, Das M, Mittal S, Sharma A, Verma Y, et al. Human papillomavirus genotyping in cervical intraepithelial neoplasia: A study from North India. Indian J Med Microbiol. 2017;35(4):551–6.
Kanthimathy SDS, Kizhakkebhagam NG, Jayalakshmi D, Nair CK, Gopinathan A. The spectrum of cytologic patterns in cervical smears of a high-risk group: Retrospective analysis of a cancer detection camp experience. Cancer Res Stat Treat. 2020;3(4):737–41. DOI: https://doi.org/10.4103/CRST.CRST_213_20
Gupta M, Agrawal A, Sharma A. Role of cytology, colposcopy and colposcopic directed biopsy in the evaluation of unhealthy cervix. Int J Reprod Contracept Obstet Gynecol. 2016;5(8):2642–6. DOI: https://doi.org/10.18203/2320-1770.ijrcog20163838
Buchade N, Kanaka RS. Study of diagnostic efficacy of visual inspection with acetic acid (VIA) in comparison with PAP smear in cervical cancer screening. Res J Med Sci. 2024;11:336–40. DOI: https://doi.org/10.36478/makrjms.2024.11.336.340
Chaudhary RD, Inamdar SA, Yadav A. Correlation of diagnostic efficacy of unhealthy cervix by cytology, colposcopy and histopathology in women of rural areas. Int J Reprod Contracept Obstet Gynecol. 2014;3(4):951–5. DOI: https://doi.org/10.5455/2320-1770.ijrcog20140343
Downloads
Published
How to Cite
Issue
Section
